459 results on '"Chen, Wilbur"'
Search Results
52. Contributors
53. Adjuvanted Intranasal Norwalk Virus-Like Particle Vaccine Elicits Antibodies and Antibody-Secreting Cells That Express Homing Receptors for Mucosal and Peripheral Lymphoid Tissues
54. Safety, Reactogenicity, and Immunogenicity of Inactivated Monovalent Influenza A(H5N1) Virus Vaccine Administered With or Without AS03 Adjuvant
55. Going Digital: Implications for Firm Value and Performance
56. Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021
57. AE Reporting and Causality
58. A Phase 2a randomized, single-center, double-blind, placebo-controlled study to evaluate the safety and preliminary efficacy of oral iOWH032 against cholera diarrhea in a controlled human infection model
59. Active Immunization with a Detoxified Endotoxin Vaccine Protects against Lethal Polymicrobial Sepsis: Its Use with CpG Adjuvant and Potential Mechanisms
60. Significant Change of Extratropical Natural Variability Associated with Tropical ENSO Anomaly
61. A site assessment tool for inpatient controlled human infection models for enteric disease pathogens
62. Desialylation of airway epithelial cells during influenza virus infection enhances pneumococcal adhesion via galectin binding
63. Vaccination in the elderly: an immunological perspective
64. The TLR4 antagonist Eritoran protects mice from lethal influenza infection
65. The antibody landscapes against Group 1 and 2 influenza virus hemagglutinin following AS03 and MF59 adjuvanted H5N1 vaccination
66. Functional and structural modifications of influenza antibodies during pregnancy
67. The Operational Feasibility of Vaccination Programs Targeting Influenza Risk Groups in the World Health Organization (WHO) African and South-East Asian Regions
68. sj-docx-2-ctj-10.1177_17407745211052473 ��� Supplemental material for A site assessment tool for inpatient controlled human infection models for enteric disease pathogens
69. sj-docx-1-ctj-10.1177_17407745211052473 ��� Supplemental material for A site assessment tool for inpatient controlled human infection models for enteric disease pathogens
70. Chinese Retail Investor Flows and Shareholder Governance
71. Spinoff Returns
72. Activist-Driven Spinoffs
73. Atmospheric Predictability of Seasonal, Annual, and Decadal Climate Means and the Role of the ENSO Cycle : A Model Study
74. Immunogenicity of Avian Influenza A/Anhui/01/2005(H5N1) Vaccine With MF59 Adjuvant: A Randomized Clinical Trial
75. Changes in polysialic acid expression on myeloid cells during differentiation and recruitment to sites of inflammation: Role in phagocytosis
76. National routine adult immunisation programmes among World Health Organization Member States: an assessment of health systems to deploy COVID-19 vaccines
77. Opportunities and Challenges in Developing a Cryptosporidium Controlled Human Infection Model for Testing Antiparasitic Agents
78. The potential effects of deploying SARS-Cov-2 vaccines on cold storage capacity and immunization workload in countries of the WHO African Region
79. Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and older
80. Going Digital: Implications for Firm Value and Performance
81. Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects
82. Vaccine‐related major cutaneous reaction size correlates with cellular‐mediated immune responses after tularaemia immunisation
83. Understanding immunosenescence and its impact on vaccination of older adults
84. Norovirus Vaccine against Experimental Human Norwalk Virus Illness
85. National Routine Adult Immunization Programs among World Health Organization Member States: An Assessment of Health Systems to Deploy Future SARS-CoV-2 Vaccines
86. The operational impact of deploying SARS-CoV-2 vaccines in countries of the WHO African Region
87. Going Digital: Implications for Firm Value and Performance.
88. COVID-19 and Lessons to Be Learned from Prior Coronavirus Outbreaks
89. Efficacy, duration of protection, birth outcomes, and infant growth associated with influenza vaccination in pregnancy: a pooled analysis of three randomised controlled trials
90. Consensus Report on Shigella Controlled Human Infection Model: Clinical Endpoints
91. Consensus Report on Shigella Controlled Human Infection Model: Conduct of Studies
92. Immune responses to O-specific polysaccharide (OSP) in North American adults infected with Vibrio cholerae O1 Inaba
93. Mitigating Cholera in the Aftermath of Cyclone Idai
94. Herpes zoster vaccine for the elderly: boosting immunity
95. Operational Feasibility of Vaccination Programs Targeting Influenza Risk Groups in the World Health Organization (WHO) African and South-East Asian Regions.
96. Asymmetric impact of tropical SST anomalies on atmospheric internal variability over the North Pacific
97. Going Digital: Implications for Firm Value and Performance
98. Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22–23 March 2017
99. The way forward for ETEC controlled human infection models (CHIMs)
100. A comparison of Lyse-It to other cellular sample preparation, bacterial lysing, and DNA fragmentation technologies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.